R&D Expense per New Drug Developed
This PDF report includes benchmarking data (in a visual, chart-based format), an comprehensive KPI definition, characteristics of high performers and technical details on measuring R&D Expense per New Drug Developed. Purchase and download this easy-to-understand, presentation-ready report immediately to compare performance levels, set attainable performance targets, and push towards best-in-class performance for this KPI.
What is R&D Expense per New Drug Developed?
The total expense incurred by a Pharmaceutical company's Research & Development (R&D) Department divided by the number of new drugs developed over the same period of time. R&D expense includes labor, investments, etc.
Why should R&D Expense per New Drug Developed be measured?
Research & Development (R&D) Expense per New Drug Developed measures the average R&D expense for each new drug developed by the pharmaceutical company over the same period of time. High R&D costs can demonstrate inefficient practices within R&D operations (i.e., employee productivity), costs associated with drugs that never make it to the marketplace (i.e., drugs that fail during clinical trials and are thus never sold) or an overstaffing of the R&D function (i.e., analysts, researchers, etc.). Since pharmaceutical R&D expenses are invariably linked to how much the drug costs in the marketplace, exorbitant R&D expenses can drive up the prices of new drugs making them that much more difficult to sell to customers. Such unmanageable prices can therefore expose the company to reputational and financial risks born from not being able to pay off its liabilities on time and high degrees of customer dissatisfaction.
Download a Sample R&D Expense per New Drug Developed
Frequently Asked Questions
Q: How do you collect and validate your data?
A: From real-world consulting engagements with Fortune 500 leaders. We’ve spent 25 years conducting original research and anonymizing data from our engagements with top companies around the world. Every single data point we collect is scrutinized by our analysts to conform to established baselines and our rigorous in-house validation process. We won’t serve it up to you unless it meets our tough standards for utility and value.
Q: How much information will my Benchmarking Report contain?
A: Enough to produce a useful benchmark. And rest assured that it’s all current, validated, and useful. We only include data that’s been collected in the last five years. And while sample sizes vary by KPI, the average is 25, and the high end can surpass 1,000.
Q: How often do you update your reports?
A: Every year. We’re constantly gathering, scouring, and processing new data. We update our reports based on trends our analysts detect in the data, as well as the demand from our consulting clients and customers like you.
Q: Your download-able reports look great. But I need something custom. Can you help?
A: Heck yes. Our crack research teams just love custom assignments, and would be delighted to perform targeted research tailored to your specific requirements. Find out just how fast and affordable this is: Email us (firstname.lastname@example.org) or call us at 866.650.2888 and one of our friendly professionals will be happy to answer all your questions.